Heart Lesions in Rheumatological Diseases

Authors

  • Khaydarov Sanjar Nizamitdinovich Samarkand State Medical University
  • Khusainova Munira Alisherovna Samarkand State Medical University
  • Khaydarova Zarrina Erkinovna Samarkand State Medical University
  • Makhmudova Khanuza Davranovna Samarkand State Medical University

DOI:

https://doi.org/10.62480/tjms.2022.vol13.pp91-94

Keywords:

echodopplercardiography, rheumatoid arthritis, systemic lupus erythematosus, systemic scleroderma, chronic spondylitis

Abstract

The study presents the results of a comparative echodopplercardiographic study of heart lesions in rheumatological diseases (rheumatoid arthritis, systemic lupus erythematosus, chronic rheumatic heart disease, systemic scleroderma and chronic spondylitis). It is shown that the frequency of heart and pericardial valve damage depends on the type of disease, which must be taken into account when ultrasound examination of the heart of patients with heumatological diseases. Rheumatic heart disease is a disease that affects the heart valves or forms a heart defect. As a result, there is heart failure, stenosis, heart rhythm disorder and other negative pathologies. It is well known that patients with rheumatological diseases (RH) — such as systemic lupus erythematosus (SLE), systemic scleroderma (SSD), ankylosing spondylitis (AS), rheumatoid arthritis (RA), are characterized by a significantly higher level of cardiovascular morbidity and mortality compared to the indicators in the general population. It has been shown that patients with RS are characterized by a faster progression of the atherosclerotic process and a high incidence of thrombosis, which cannot be fully explained by the influence of traditional factors risk of cardiovascular pathology. Therefore, a number of authors have suggested the role of inflammation as a link between RH and atherosclerosis, damage to target organs, where inflammatory mediators and pro-inflammatory cytokines act as intermediaries. At the same time, the profile of inflammatory markers differs depending on the type of RH, which may manifest itself in the features of target organ damage, however, this assumption has not been practically investigated before.

References

Alisherovna, K. M., Davranovna, M. H., & Nizametdinovich, K. S. (2022). Chronic Heart Failure in

Women. CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES, 3(1), 21-25.

Alisherovna, K. M., Tatlibayevich, Y. S., Toshtemirovna, E. M. M., & Nizamitdinovich, H. S.

(2021). Diagnostic Significance Daily Monitoring of Blood Pressure in Young Women (Under 40

Years Old) with Arterial Hypertension. CENTRAL ASIAN JOURNAL OF MEDICAL AND

NATURAL SCIENCES, 2(5), 461-465.

Alisherovna, K. M., Toshtemirovna, E. M. M., Duskobilovich, B. S., & Umirxanovna, K. G. (2022).

DYSFUNCTION LEFT VENTRICULAR IN BRONCHIAL ASTHMA. Spectrum Journal of

Innovation, Reforms and Development, 4, 216-221.

Buribayevich, N. M. (2022). APPLICATIONS THE DRUG NICOMEX AT TREATMENT OF

PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS. Web of

Scientist: International Scientific Research Journal, 3(5), 597-605.

Buribayevich, N. M. (2022). Treatment of Chronic Heart Failure in Patients with Type 2 Diabetes

Mellitus. CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES, 3(1), 183-186.

Downloads

Published

2022-10-18

Issue

Section

Articles

How to Cite

Heart Lesions in Rheumatological Diseases. (2022). Texas Journal of Medical Science, 13, 91-94. https://doi.org/10.62480/tjms.2022.vol13.pp91-94

Most read articles by the same author(s)